
Home » Aegerion Shares Rise on Report of High Cholesterol Drug
Aegerion Shares Rise on Report of High Cholesterol Drug
Aegerion Pharmaceuticals rose after a U.S. regulatory staff report said a plan to manage the risks of the company’s drug supports its approval in adults with the most life-threatening forms of severely high cholesterol.
Bloomberg
Bloomberg
Upcoming Events
-
28Sep
-
28Sep
-
11Oct
-
16Oct
-
26Oct
-
08Nov